Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,021,048
-
Total 13F shares
-
72,890,896
-
Share change
-
-620,756
-
Total reported value
-
$9,404,213,953
-
Put/Call ratio
-
69%
-
Price per share
-
$129.04
-
Number of holders
-
374
-
Value change
-
-$5,607,244
-
Number of buys
-
184
-
Number of sells
-
154
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock (SRPT) as of Q4 2019
As of 31 Dec 2019,
Sarepta Therapeutics, Inc. - Common Stock (SRPT) was held by
374 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
72,890,896 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., SANDS CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, Capital Research Global Investors, STATE STREET CORP, Invesco Ltd., and Avoro Capital Advisors LLC.
This page lists
377
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.